Sandbox Reserved 896: Difference between revisions

Line 4:

This is a default text for your page ''''''. Click above on '''edit this page''' to modify. Be careful with the < and > signs.

You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.

==Overview==

Human bromodomain-containing protein 2 (BRD2) is a highly conserved and ubiquitously expressed protein involved in transcriptional regulation and recognition of post-translational histone modifications. BRD2 is a bromodomain and extra-terminal domain (BET) family protein, which are characterized by the presence of two adjacent bromodomains as well as an extra-terminal domain. Bromodomain and extra terminal domain (BET) family proteins are a group of related proteins involved in the specific recognition of acetylated lysine residues on chromatin and subsequent transcriptional activation [2]. As a BET protein, BRD2 follows this structural motif with its structure consisting of bromodomain 1 (BRD2-BD1) at the N-terminus, bromodomain 2 (BRD2-BD2), and an N-extra-terminal (NET) domain. Human BRD2 is encoded by the gene BRD2, which consists of 11 exons that cover more than 6 kb of genomic DNA [1]. This gene was formerly known as really interesting new gene 3 (RING3) but was later renamed to BRD2.

== Function ==

Human BRD2 protein is a Serine-Threonine kinase found ubiquitously amongst the nuclear envelope of all cell types. The activity of BRD2 is increased during cell proliferation. BRD2 specifically recognizes an N-acetyl-lysine residue at position 12 of histone H4 via a homo-2-mer complex of BD1 domains. The BRD2-BD1 domain recognizes the H4 tail only when lysine-12 is acetylated. This recognition is mediated through the binding of the hypoacetylated side chain of lysine at position 8 of H4 with the interface between dimerized BRD2-BD1 domains [3]. BRD2 has also shown in vitro interaction with N-acetyl-lysine at position 5 of K12, but this interaction has not been shown to involve lysine-8 of H4 [3]. It is presumed that one of the functions of this recognition is to prevent deletion or erasure of post-translational histone markers during the mitotic cell cycle. The transcriptional regulation activity of BRD2 is also mediated through its positive regulation of E2F-dependent cell cycle progression (direct stimulation of E2F reporter activity) [1]. As E2F’s central function is to promote the synthesis of proteins needed for G1 to S transition, BRD2-BD1 is directly implicated in the regulation of the cell cycle.

[[Image:BRD2BD1SurfaceView.png]]

[[Image:ProteopediaTest.png]]

Sandbox Reserved 896: Difference between revisions

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 4: / Line 4: @@
 This is a default text for your page ''''''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
 You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
+==Overview==
+Human bromodomain-containing protein 2 (BRD2) is a highly conserved and ubiquitously expressed protein involved in transcriptional regulation and recognition of post-translational histone modifications. BRD2 is a bromodomain and extra-terminal domain (BET) family protein, which are characterized by the presence of two adjacent bromodomains as well as an extra-terminal domain. Bromodomain and extra terminal domain (BET) family proteins are a group of related proteins involved in the specific recognition of acetylated lysine residues on chromatin and subsequent transcriptional activation [2]. As a BET protein, BRD2 follows this structural motif with its structure consisting of bromodomain 1 (BRD2-BD1) at the N-terminus, bromodomain 2 (BRD2-BD2), and an N-extra-terminal (NET) domain. Human BRD2 is encoded by the gene BRD2, which consists of 11 exons that cover more than 6 kb of genomic DNA [1]. This gene was formerly known as really interesting new gene 3 (RING3) but was later renamed to BRD2.
 == Function ==
+Human BRD2 protein is a Serine-Threonine kinase found ubiquitously amongst the nuclear envelope of all cell types. The activity of BRD2 is increased during cell proliferation. BRD2 specifically recognizes an N-acetyl-lysine residue at position 12 of histone H4 via a homo-2-mer complex of BD1 domains. The BRD2-BD1 domain recognizes the H4 tail only when lysine-12 is acetylated. This recognition is mediated through the binding of the hypoacetylated side chain of lysine at position 8 of H4 with the interface between dimerized BRD2-BD1 domains [3]. BRD2 has also shown in vitro interaction with N-acetyl-lysine at position 5 of K12, but this interaction has not been shown to involve lysine-8 of H4 [3]. It is presumed that one of the functions of this recognition is to prevent deletion or erasure of post-translational histone markers during the mitotic cell cycle. The transcriptional regulation activity of BRD2 is also mediated through its positive regulation of E2F-dependent cell cycle progression (direct stimulation of E2F reporter activity) [1]. As E2F’s central function is to promote the synthesis of proteins needed for G1 to S transition, BRD2-BD1 is directly implicated in the regulation of the cell cycle.
+[[Image:BRD2BD1SurfaceView.png]]
 [[Image:ProteopediaTest.png]]